Impact of sex, age at onset, and anti-cN1A antibodies on sporadic inclusion body myositis.

Autoantibodies, gender, age of onset, and disease duration may influence the clinical presentation of IBM, highlighting the need for a precision medicine approach that considers these factors along with the underlying mechanisms of the disease.